Stay updated on Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The webpage has updated its time slot availability by adding several new dates in 2025 and 2026 while removing some previously listed dates from late 2024.
    Difference
    0.5%
    Check dated 2025-05-08T13:56:17.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T06:24:37.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new study involving the drug carboplatin and gemcitabine, replacing the previous focus on enfortumab vedotin. Key collaborators have been updated to include Merck Sharp & Dohme LLC and Seagen Inc.
    Difference
    20%
    Check dated 2025-04-16T20:41:07.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 27, 2024.
    Difference
    0.2%
    Check dated 2025-04-09T16:00:35.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous estimated update date of December 27, 2024, and revision version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-02T00:23:53.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-24T23:10:56.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.